Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Korea's Green Cross Begins "Test Production" of Flu Vaccine

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korean pharmaceutical company Green Cross recently started "test production" of its own A/H1N1 flu vaccine, after receiving a virus strain from the UK's National Institution for Biological Standards and Control and from the Centers for Disease Control and Prevention of the U.S

You may also be interested in...



South Korea Gearing Up To Fight Tuberculosis

To eliminate perceptions that South Korea stands out among OECD countries as a safe haven for TB, the government is rolling out specific tools to combat the deadly lung disease.

Korea's Green Cross Strengthens Vaccine Supply Chain For Growing Export Demand

SEOUL - South Korea's leading vaccine producer Green Cross has opened and begun operation of a vaccine egg farm to build up a stable channel for the supply of flu vaccine eggs to the pharma's vaccine plant in Hwasoon, Southwest of Seoul. The company is preparing for increased domestic competition, but it also benefiting from a pickup in foreign demand

Korea's Green Cross Strengthens Vaccine Supply Chain For Growing Export Demand

SEOUL - South Korea's leading vaccine producer Green Cross has opened and begun operation of a vaccine egg farm to build up a stable channel for the supply of flu vaccine eggs to the pharma's vaccine plant in Hwasoon, Southwest of Seoul. The company is preparing for increased domestic competition, but it also benefiting from a pickup in foreign demand

Related Content

UsernamePublicRestriction

Register

PS140995

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel